Related references
Note: Only part of the references are listed.Convalescent plasma as a potential therapy for COVID-19
Long Chen et al.
LANCET INFECTIOUS DISEASES (2020)
The convalescent sera option for containing COVID-19
Arturo Casadevall et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Deployment of convalescent plasma for the prevention and treatment of COVID-19
Evan M. Bloch et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
Kai Duan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
Bette Korber et al.
CELL (2020)
SARS-CoV-2 Infections and Serologic Responses from a Sample of US Navy Service Members - USS Theodore Roosevelt, April 2020
Daniel C. Payne et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
A Randomized Trial of Convalescent Plasma for COVID-19-Potentially Hopeful Signals
Arturo Casadevall et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19 A Randomized Clinical Trial
Ling Li et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Early safety indicators of COVID-19 convalescent plasma in 5000 patients
Michael J. Joyner et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses
Fabian Schmidt et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Convergent antibody responses to SARS-CoV-2 in convalescent individuals
Davide F. Robbiani et al.
NATURE (2020)
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
Quan-Xin Long et al.
NATURE MEDICINE (2020)
An mRNA Vaccine against SARS-CoV-2-Preliminary Report
L. A. Jackson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques
Wei Deng et al.
SCIENCE (2020)
Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset
Josee Perreault et al.
BLOOD (2020)
Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 Spike
Jeremie Prevost et al.
CELL REPORTS MEDICINE (2020)
Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience
Jae-Hoon Ko et al.
ANTIVIRAL THERAPY (2018)
Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus Infection
Ivan F. N. Hung et al.
CLINICAL INFECTIOUS DISEASES (2011)
Use of convalescent plasma therapy in SARS patients in Hong Kong
Y Cheng et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)